{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237119,Language='FR')/Transcripts"}},"ID":20237119,"Language":"FR","BusinessShortNumber":"23.7119","BusinessType":14,"BusinessTypeName":"Heure des questions. Question","BusinessTypeAbbreviation":"Qst.","Title":"Marges de distribution \u00e9lev\u00e9es pour les m\u00e9dicaments","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>En r\u00e9ponse \u00e0 l'ip. 22.4362, le Conseil f\u00e9d\u00e9ral confirme une r\u00e9organisation des marges de distribution dans la d\u00e9livrance des m\u00e9dicaments, surtout pour les m\u00e9dicaments bon march\u00e9. Il s\u00e9curise ainsi les prestations des prestataires - pharmacies, m\u00e9decins et polycliniques - qui d\u00e9livrent les m\u00e9dicaments aux frais de I'LAMal. Les prix d\u00e9part usine de ces m\u00e9dicaments restent les m\u00eames.</p><p>Cela ne va-t-il pas \u00e0 l'encontre des efforts des travails sur les goulots d'\u00e9tranglement de l'approvisionnement\u00a0?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":"<p>Le Conseil f\u00e9d\u00e9ral est conscient de la probl\u00e9matique croissante que repr\u00e9sente la s\u00e9curit\u00e9 de l'approvisionnement en m\u00e9dicaments. Les raisons des perturbations de l'approvisionnement sont d'ordre divers et rev\u00eatent le plus souvent un caract\u00e8re international. Cela \u00e9tant, les produits anciens et bon march\u00e9, en particulier, sont de plus en plus concern\u00e9s. C'est pourquoi, dans le cadre du deuxi\u00e8me volet de mesures de ma\u00eetrise des co\u00fbts, le Conseil f\u00e9d\u00e9ral pr\u00e9voit d'introduire un r\u00e9examen diff\u00e9renci\u00e9 pour les crit\u00e8res d'efficacit\u00e9, d'ad\u00e9quation et d'\u00e9conomicit\u00e9. Sur cette base, certains m\u00e9dicaments vitaux et bon march\u00e9 pourront \u00e0 l'avenir ne plus faire l'objet d'une baisse de prix. Dans l'intervalle, sur demande des titulaires de l'autorisation, l'OFSP peut exceptionnellement renoncer \u00e0 une baisse de prix ou accorder une hausse de prix pour des m\u00e9dicaments essentiels sur le plan de l'approvisionnement. Cette approche cibl\u00e9e est pr\u00e9f\u00e9rable \u00e0 des augmentations de prix g\u00e9n\u00e9ralis\u00e9es.</p>","FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":"\/Date(1678060800000)\/","SubmittedBy":"Nicolet Jacques","BusinessStatus":229,"BusinessStatusText":"Liquid\u00e9","BusinessStatusDate":"\/Date(1678060800000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"D\u00e9partement de l'int\u00e9rieur","ResponsibleDepartmentAbbreviation":"DFI","IsLeadingDepartment":true,"Tags":"9|15|2841","Category":null,"Modified":"\/Date(1694445025537)\/","SubmissionDate":"\/Date(1677628800000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":5118,"SubmissionLegislativePeriod":51,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Politique de s\u00e9curit\u00e9|\u00c9conomie|Sant\u00e9"}}